Media Summary: Are you taking multiple medicines for health conditions? It can be really easy to: Forget to take your medicines Miss a dose ... Susan Zuk from the Office of Pharmaceutical Quality provides an update on how the FDA fulfills its GDUFA II commitment to add ... Kristina Lauritsen, PhD, CDER combination products regulatory policy advisor for the Office of Executive Programs, discusses the ...

Doseaid Showcase - Detailed Analysis & Overview

Are you taking multiple medicines for health conditions? It can be really easy to: Forget to take your medicines Miss a dose ... Susan Zuk from the Office of Pharmaceutical Quality provides an update on how the FDA fulfills its GDUFA II commitment to add ... Kristina Lauritsen, PhD, CDER combination products regulatory policy advisor for the Office of Executive Programs, discusses the ... Konrad van Eck outlines features of the newest system integrator solutions offered by D-Tools, with exciting upgrades such as ... Great to collaborate with the Ahmedabad Ophthalmic Society for a successful CME event on the Aurolab Magnus – Beyond EDOF ... Yiyue (Cynthia) Zhang, PhD, from the Division of New Drug Study Integrity (DNDSI) and Monica Javidnia, PhD and Kara ...

Gajendiran Mahadevan, PhD, from the Division of New Drug Study Integrity (DNDSI), presents In Vitro BE Case Study. 00:00 – In ... Doug Pham, PharmD, JD, Associate Director for Clinical Policy, presents Clinical BA/BE Case Study. 00:00 – Clinical BA/BE Case ... This presentation provided key principles for comparative analyses (CA) and established understanding of essential CA ... Sean Kassim, PhD, Director of Office of Study Integrity and Surveillance (OSIS) and ShaAvhrée Buckman-Garner, MD, PhD, ... Zhou Chen, MD, PhD and Lynda Lanning, DVM, DABT from the Good Laboratory Practice (GLP) Team of the Division of New ... Xingfang Li, MD and Xikui Chen, PhD, from the Division of Generic Drug Study Integrity (DGDSI), and Li-Hong Yeh, PhD, from the ...

Lynda Lanning, DVM, DABT and Yiyue (Cynthia) Zhang, PhD from Division of New Drug Study Integrity (DNDSI) present Animal ... This presentation described different long-acting injectable (LAI) products and recognized regulatory and scientific challenges for ... This video provided an overview of FDA's review process for combination products and presented recent updates in combination ... This presentation explored the critical need for improved In Vitro Release Testing (IVRT) methods for complex drug products. Sarmistha Sanyal, PhD, from the Division of Generic Drug Study Integrity (DGDSI) presents Analytical BA/BE Case Study. 00:00 ...

Photo Gallery

DoseAid Showcase
Introducing DoseAid
Dose Administration Aids
What’s New in the Inactive Ingredient Database (IID)?
Role of the Product Jurisdiction Team in the Medical Product Development Process
ISE 2023 | D-Tools booth product showcase | System Integrator Software Solutions
Aurolab Magnus - Beyond EDOF IOL | CME | Ahmedabad
Office of Study Integrity and Surveillance (OSIS) Workshop 2022 - Day 1 – Session 2
Office of Study Integrity and Surveillance (OSIS) Workshop 2022 - Day 2 – Case Study 5
Office of Study Integrity and Surveillance (OSIS) Workshop 2022 - Day 2 – Case Study 3
AGDD 2024 | D1S14 - Drug-Device Combination Products – A New Methodology for Evaluation
Office of Study Integrity and Surveillance (OSIS) Workshop 2022 - Day 1 – Welcome & Session 1
View Detailed Profile
DoseAid Showcase

DoseAid Showcase

DoseAid

Introducing DoseAid

Introducing DoseAid

DoseAid

Dose Administration Aids

Dose Administration Aids

Are you taking multiple medicines for health conditions? It can be really easy to: Forget to take your medicines Miss a dose ...

What’s New in the Inactive Ingredient Database (IID)?

What’s New in the Inactive Ingredient Database (IID)?

Susan Zuk from the Office of Pharmaceutical Quality provides an update on how the FDA fulfills its GDUFA II commitment to add ...

Role of the Product Jurisdiction Team in the Medical Product Development Process

Role of the Product Jurisdiction Team in the Medical Product Development Process

Kristina Lauritsen, PhD, CDER combination products regulatory policy advisor for the Office of Executive Programs, discusses the ...

ISE 2023 | D-Tools booth product showcase | System Integrator Software Solutions

ISE 2023 | D-Tools booth product showcase | System Integrator Software Solutions

Konrad van Eck outlines features of the newest system integrator solutions offered by D-Tools, with exciting upgrades such as ...

Aurolab Magnus - Beyond EDOF IOL | CME | Ahmedabad

Aurolab Magnus - Beyond EDOF IOL | CME | Ahmedabad

Great to collaborate with the Ahmedabad Ophthalmic Society for a successful CME event on the Aurolab Magnus – Beyond EDOF ...

Office of Study Integrity and Surveillance (OSIS) Workshop 2022 - Day 1 – Session 2

Office of Study Integrity and Surveillance (OSIS) Workshop 2022 - Day 1 – Session 2

Yiyue (Cynthia) Zhang, PhD, from the Division of New Drug Study Integrity (DNDSI) and Monica Javidnia, PhD and Kara ...

Office of Study Integrity and Surveillance (OSIS) Workshop 2022 - Day 2 – Case Study 5

Office of Study Integrity and Surveillance (OSIS) Workshop 2022 - Day 2 – Case Study 5

Gajendiran Mahadevan, PhD, from the Division of New Drug Study Integrity (DNDSI), presents In Vitro BE Case Study. 00:00 – In ...

Office of Study Integrity and Surveillance (OSIS) Workshop 2022 - Day 2 – Case Study 3

Office of Study Integrity and Surveillance (OSIS) Workshop 2022 - Day 2 – Case Study 3

Doug Pham, PharmD, JD, Associate Director for Clinical Policy, presents Clinical BA/BE Case Study. 00:00 – Clinical BA/BE Case ...

AGDD 2024 | D1S14 - Drug-Device Combination Products – A New Methodology for Evaluation

AGDD 2024 | D1S14 - Drug-Device Combination Products – A New Methodology for Evaluation

This presentation provided key principles for comparative analyses (CA) and established understanding of essential CA ...

Office of Study Integrity and Surveillance (OSIS) Workshop 2022 - Day 1 – Welcome & Session 1

Office of Study Integrity and Surveillance (OSIS) Workshop 2022 - Day 1 – Welcome & Session 1

Sean Kassim, PhD, Director of Office of Study Integrity and Surveillance (OSIS) and ShaAvhrée Buckman-Garner, MD, PhD, ...

Office of Study Integrity and Surveillance (OSIS) Workshop 2022 - Day 2 – Case Study 1

Office of Study Integrity and Surveillance (OSIS) Workshop 2022 - Day 2 – Case Study 1

Zhou Chen, MD, PhD and Lynda Lanning, DVM, DABT from the Good Laboratory Practice (GLP) Team of the Division of New ...

Office of Study Integrity and Surveillance (OSIS) Workshop 2022 - Day 1 – Session 3

Office of Study Integrity and Surveillance (OSIS) Workshop 2022 - Day 1 – Session 3

Xingfang Li, MD and Xikui Chen, PhD, from the Division of Generic Drug Study Integrity (DGDSI), and Li-Hong Yeh, PhD, from the ...

Office of Study Integrity and Surveillance (OSIS) Workshop 2022 - Day 2 – Case Study 2

Office of Study Integrity and Surveillance (OSIS) Workshop 2022 - Day 2 – Case Study 2

Lynda Lanning, DVM, DABT and Yiyue (Cynthia) Zhang, PhD from Division of New Drug Study Integrity (DNDSI) present Animal ...

AGDD 2024 | D2S07-The Journey of First Approvals of Complex Generic Long-acting Injectable Products

AGDD 2024 | D2S07-The Journey of First Approvals of Complex Generic Long-acting Injectable Products

This presentation described different long-acting injectable (LAI) products and recognized regulatory and scientific challenges for ...

REdI 2024 | D1S09 - Combination Products: Updates and Best Practices

REdI 2024 | D1S09 - Combination Products: Updates and Best Practices

This video provided an overview of FDA's review process for combination products and presented recent updates in combination ...

AGDD 2024 | D1S04 - Application of Adaptive Perfusion as In Vitro Release Testing Method...

AGDD 2024 | D1S04 - Application of Adaptive Perfusion as In Vitro Release Testing Method...

This presentation explored the critical need for improved In Vitro Release Testing (IVRT) methods for complex drug products.

Office of Study Integrity and Surveillance (OSIS) Workshop 2022 - Day 2 – Case Study 4

Office of Study Integrity and Surveillance (OSIS) Workshop 2022 - Day 2 – Case Study 4

Sarmistha Sanyal, PhD, from the Division of Generic Drug Study Integrity (DGDSI) presents Analytical BA/BE Case Study. 00:00 ...

DAI-50 at INTERPHEX 2026 | AI-Based Automated Visual Inspection for Pharma

DAI-50 at INTERPHEX 2026 | AI-Based Automated Visual Inspection for Pharma

At INTERPHEX 2026, Dabrico